Donor Selection
- PMID: 31314316
- Bookshelf ID: NBK543665
- DOI: 10.1007/978-3-319-50026-3_3
Donor Selection
Excerpt
Allogeneic haematopoietic stem cell transplant (HSCT) is the treatment of choice for a variety of malignant and non-malignant disorders. The aim of HSCT is to replace the patient’s haematopoiesis with that taken from a donor, and a prerequisite is the identification of a suitable donor. It is an intense and demanding process and puts considerable strain on both recipients and donors. The choice of donor has an impact on the transplantation process from scheduling to outcome. There are several common donor issues whether the donor is related or unrelated including eligibility, confidentiality, informed consent and right to refuse consent.
Copyright 2018, EBMT and the Author(s).
Sections
References
-
- Apperley J, Carreras E, Gluckman E, Masszi T. Haematopoeitic stem cell transplantation. 6th revised ed. 2012.
-
- Hutt D, Nehari M, Munits-Shenkar D, Akalay Y, Toren A, Bielorai B. Haematopoietic stem cell donation: psychological perspectives of paediatric sibling donors and their parents. Bone Marrow Transplant. 2015;50:1–6. - PubMed
-
- Kisch, AM. Allogeneic stem cell transplant. Patient and sibling donors perspective. Malmo University. 2015.
-
- Kollman C, Howe CW, Ansetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors. Blood. 2001;98:2043–51. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials